These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2198029)

  • 21. Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor.
    Fitzgerald JR; Loughman A; Keane F; Brennan M; Knobel M; Higgins J; Visai L; Speziale P; Cox D; Foster TJ
    Mol Microbiol; 2006 Jan; 59(1):212-30. PubMed ID: 16359330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atherosclerotic lesions from the reduction of pulmonary emboli.
    Sevitt S; Walton KW
    Atherosclerosis; 1986 Feb; 59(2):173-85. PubMed ID: 3964343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor XIIIa cross-links lipoprotein(a) with fibrinogen and is present in human atherosclerotic lesions.
    Romanic AM; Arleth AJ; Willette RN; Ohlstein EH
    Circ Res; 1998 Aug; 83(3):264-9. PubMed ID: 9710118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma protein insudation as an index of early coronary atherogenesis.
    Zhang Y; Cliff WJ; Schoefl GI; Higgins G
    Am J Pathol; 1993 Aug; 143(2):496-506. PubMed ID: 8342598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fibronectin content of the intima of normal and atherosclerotic arteries].
    Shekhonin BV; Kotelianskiĭ VE; Idel'son GL; Rukosuev VS
    Kardiologiia; 1985 Aug; 25(8):9-12. PubMed ID: 3906224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice.
    Lou XJ; Boonmark NW; Horrigan FT; Degen JL; Lawn RM
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12591-5. PubMed ID: 9770530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular interactions in human atherosclerotic plaques.
    Smith EB
    Am J Pathol; 1977 Mar; 86(3):665-74. PubMed ID: 65917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procoagulant properties of atherosclerotic aortas.
    Sueishi K; Ichikawa K; Nakagawa K; Kato K; Elsayed YA; Namoto M
    Ann N Y Acad Sci; 1995 Jan; 748():185-92; discussion 192-3. PubMed ID: 7695164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free N-terminal fibronectin 30-kD-domain mediates binding of soluble fibrin to gelfiltered unstimulated thrombocytes.
    Hörmann H; Richter H; Jelinić V
    Thromb Res; 1988 Aug; 51(3):283-93. PubMed ID: 3175984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mural thrombosis and atherogenesis in coronary arteries and aorta. An investigation using antifibrin and antiplatelet sera.
    Hudson J; McCaughey WT
    Atherosclerosis; 1974; 19(3):543-53. PubMed ID: 4133380
    [No Abstract]   [Full Text] [Related]  

  • 31. Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectin-binding site.
    Makogonenko E; Tsurupa G; Ingham K; Medved L
    Biochemistry; 2002 Jun; 41(25):7907-13. PubMed ID: 12069579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial interactions of platelets and plasma proteins in flowing non-anticoagulated human blood with the artificial surfaces Dacron and PTFE.
    Roald HE; Barstad RM; Bakken IJ; Roald B; Lyberg T; Sakariassen KS
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):355-63. PubMed ID: 8075307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical detection of apolipoprotein A-I and B-100 in canine atherosclerotic lesions.
    Sako T; Uchida E; Kagawa Y; Hirayama K; Nakade T; Taniyama H
    Vet Pathol; 2003 May; 40(3):328-31. PubMed ID: 12724575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of fibronectin, Von Willebrand factor, and fibrinogen in platelet interaction with solid substrata.
    Lahav J; Hynes RO
    J Supramol Struct Cell Biochem; 1981; 17(4):299-311. PubMed ID: 6977039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots.
    Sangrar W; Koschinsky ML
    Biochem Cell Biol; 2000; 78(4):519-25. PubMed ID: 11012092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions.
    Kleindienst R; Xu Q; Willeit J; Waldenberger FR; Weimann S; Wick G
    Am J Pathol; 1993 Jun; 142(6):1927-37. PubMed ID: 8099471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin.
    Matter CM; Schuler PK; Alessi P; Meier P; Ricci R; Zhang D; Halin C; Castellani P; Zardi L; Hofer CK; Montani M; Neri D; Lüscher TF
    Circ Res; 2004 Dec; 95(12):1225-33. PubMed ID: 15539632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.
    Plow EF; Pierschbacher MD; Ruoslahti E; Marguerie GA; Ginsberg MH
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8057-61. PubMed ID: 3877935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of fibrinogen/fibrin and fibronectin with collagen.
    Hörmann H; Jilek F
    Artery; 1980; 8(5):482-6. PubMed ID: 7213052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.